asparagine has been researched along with Hemolysis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dohi, Y; Sasaki, T; Takahashi, N; Yonemasu, K | 1 |
| Circolo, A; Jing, H; Narayana, SV; Volanakis, JE; Wang, Y; Xu, Y | 1 |
| Distler, A; Nast, HP; Schreiber, G; Walter, U | 1 |
3 other study(ies) available for asparagine and Hemolysis
| Article | Year |
|---|---|
A study of the role of the asparagine-linked sugar chains of human complement subcomponent C1q in its biological activities.
Topics: Antigen-Antibody Complex; Asparagine; Complement Activating Enzymes; Complement C1q; Glycoproteins; Hemolysis; Humans; Immunoglobulin Fc Fragments; Metabolic Clearance Rate; Neuraminidase; Structure-Activity Relationship | 1984 |
Mutational analysis of the primary substrate specificity pocket of complement factor B. Asp(226) is a major structural determinant for p(1)-Arg binding.
Topics: Amino Acid Sequence; Asparagine; Aspartic Acid; Catalytic Domain; Complement C3-C5 Convertases; Complement Factor B; Complement Factor D; Elapid Venoms; Hemolysis; Models, Molecular; Molecular Sequence Data; Mutation; Sequence Homology, Amino Acid; Substrate Specificity | 2000 |
[Inactivation of alpha-L-asparaginyl-angiotensin II by erythrocytes from healthy persons, and from patients with various forms of hypertension, or liver diseases].
Topics: Adult; Aminopeptidases; Angiotensin II; Asparagine; Cell Membrane; Endopeptidases; Erythrocytes; Female; Hemolysis; Humans; Hyperaldosteronism; Hypertension, Malignant; Hypertension, Renal; Liver Diseases; Male; Middle Aged | 1974 |